The (Post-COVID) Future of Cardiovascular Disease Prevention: At...
Transcript of The (Post-COVID) Future of Cardiovascular Disease Prevention: At...
The (Post-COVID) Future of Cardiovascular Disease
Prevention: At A Crossroads?
Laurence S. Sperling, M.D., FACC, FACP,FAHA, FASPC
Katz Professor in Preventive Cardiology
Founder, Emory Center for Heart Disease Prevention
Professor of Global Health
Emory University
Executive Director, Million Hearts
CDC / NCCDPHP / DHDSP/CMS
Past President , American Society for Preventive Cardiology
Co-Chair ACC Diabetes & Cardiometabolic Working Group
Chair World Heart Federation Roadmap on Prevention of CVD
Among People Living with Diabetes
About the Presenter
Laurence S. Sperling, MD
DISCLOSURES
No potential conflicts
related to this
presentation
Opinions expressed do not necessarily
reflect the opinions of the US Dept of
HHS, the Public Health Service, the
Centers for Disease Control and
Prevention, or the presenters affiliated
institutions. Use of trade names is for
identification only and does not imply
endorsement by any of the groups
named above.
(Post-COVID) Future of CVD Prevention
• Past
• Present
• The Future
(Post-COVID) Future of CVD Prevention
• Past – BC (Before COVID)
• Present
• The Future
Father of CV Prevention: Paul Dudley White
• Advocate for prevention of heart disease
• Major impetus behind Framingham HS
• Helped oversee creation of NHLBI & AHA
• Eisenhower’s physician following 1955 MI
• “Exercise more. Eat healthy. Learn your family’s medical Hx”
Paul Dudley White’s last fellow at MGH
• J. Willis Hurst• Chair Emory’s DOM
35 yrs
• Hurst’s The Heart, 14th Ed.
• AHA President
• Lyndon Johnson’s physician , MI April 9, 1972
• Encouraged start of Prev Card at Emory
• 2011 (90 yo)
“ In 1961 with just two words, Bill (Kannel)
helped to change our understanding of the
underlying causes of heart disease and stroke,
and with two words, the entire field of
preventive cardiology was born.”Daniel Levy
Current Framingham Heart Study Director
Wong N., Sperling L. , Baum S. The ASPC: Our 30 Year Legacy, Clinical
Cardiology, 2016
Concept of cardiovascular “risk
factors”
Kannel et al, Ann Intern Med 1961
Age, sex, hypertension, hyperlipidemia,
smoking, diabetes, (family history), (obesity)
“We cannot be a strong nation
unless we are a healthy nation…”
Franklin D. RooseveltDedication of NIH Campus
Bethesda, MD
October, 1940
“CVD is the biggest epidemic (pandemic)
ever known to mankind- We need strategies to
address epidemics…” Salim Yusuf
President WHF
Europrevent 2013, Rome
“Secondary Prevention is urgent….”
Valentin FusterWCC 2016, CDMX
Epidemics / Pandemics
Our World Has Changed Since January 2020……
(Post-COVID) Future of CVD Prevention
• Past
• Present
• The Future
Bidirectional Interaction Between CVD and
COVID-19
Nishiga M, et al. Nature Reviews Cardiology 2020; 17: 543-558
CMR in Patients Recovering from COVID-19
• 100 pts Frankfurt, Germany
• Median 71 days from
COVID
• Cardiac involvement 78%
• Active myocardial
inflammation 60%
• hs-TnT detectable 71%
• Independent of preexisting
conditions, severity
• Bx with severe findings-
acute lymphocytic
infiltration
Puntmann VO, et al. JAMA Cardiol. Online
July 27,2020
Impact of COVID on CV Care (4/25/20)
•
Lange SJ, Ritchey MD, Goodman AB, et al. Potential Indirect Effects
of the COVID-19 Pandemic on Use of Emergency Departments for
Acute Life-Threatening Conditions — United States, January–May
2020. MMWR Morb Mortal Wkly Rep. ePub: 22 June 2020. DOI:
http://dx.doi.org/10.15585/mmwr.mm6925e2
Impact of COVID(MMWR)
Stokes EK, Zambrano LD, Anderson KN, et al. Coronavirus Disease 2019 Case Surveillance — United States, January 22–May 30, 2020. MMWR Morb Mortal Wkly Rep 2020;69:759–765. DOI: http://dx.doi.org/10.15585/mmwr.mm6924e2
https://www.cdc.gov/mmwr/i
ndex.html
Delay or Avoidance of Medical Care
Because of COVID-19-Related Concerns-U.S., June 2020
• Estimated 41% of U.S. adults delayed or avoided care (12% urgent / emergent; 32% routine)
• Greater in those with 2 or more medical conditions (aPR =1.9)
• Might contribute to reported excess deaths directly or indirectly related to COVID-19
• Inform approaches and communication encouraging safe routine, urgent and emergency care
MMWR. September 11, 2020/ 69(36); 1250-1257
Weeks to
Months
Morb
idit
y a
nd M
ort
alit
y
Curve
#1Acute COVID-19
Infections
Curve
#2
Months Years
Curve
#3
Curve #5
Decades
Delays in Urgent Care,
Lack of Guideline-
Directed Care
Neglected Chronic
Conditions, Rehab/LTAC
Care
Curve
#4
Iterative COVID-
19 Infections
Mental Health and
Economic Burden
Adapted with permission from Victor Tseng, MD
Kohli P, Virani SS. Circulation. 2020 Jul
14;142(2):98-100.
Recommendations for Patient Visits During
COVID-19 Pandemic
• Don’t defer patient visits
• use telehealth including telephone if at all possible
• At each visit:
-Ask about symptoms
-Encourage EMS/ER for acute symptoms
-Remind patients about safety
-Ensure adequate medication refills and access
-Inquire about physical activity and nutrition
habits
-Use the full care team to enhance patient care
Khera A, et al. Am J Prev Card;Volume 1: March 2020
Influenza Vaccination for CV Prevention
• AHA/ ACC Class I Recommendation for
Secondary Prevention (LOE B)
• MI’s 6 X greater within week of influenza
• IV reduces burden of influenza-associated illness
including CV events (15-45%- similar RRR as
other GDMT)
• Readiness for upcoming influenza season needed
– Health systems and team-based approaches
cdc.gov/flu/high risk/ heart disease
Davis MM, et al. Circulation 2006;114(14)
Kwong JC, et l. NEJM 2018;378(4)
MacIntyre CR, et al. Heart 2016; 102(4)
Cardiovascular Health,
Prevention, and CV Care Must
Remain a Priority during the
Pandemic
Concerning Directional Change
Heart Disease and Stroke Trends 1950-2015
• CVD leading cause of
mortality since 1910, (with
exception of flu pandemic
1918-1920)
• Racial/ ethnic disparities
persistent in CVD mortality
since 1968
• Current stagnation- upward
trends
Mensah GA, Wei GS, Sorlie PD, et al. Decline in
Cardiovascular Mortality – Possible Causes and
Implications. Circulation Research. 2017;120:366-
380.
Sidney S, et al. JAMA Cardiol 2016;1:594-9
Van Dyke M, et al. MMWR Surveill Summ. 2018;
67:1-11
Alarming Mortality Rate Changes Among Adults Aged 35–64
Percent change in heart disease
rate, 2010–2017 (% of counties)
Ritchey MD et al. Trends Cardiovasc Med. 2019;pii:S1050-1738(19)30134-3. Hall EW et al. Stroke. 2019;50(12):3355-3359
Percent change in
stroke rate, 2010–2016 (% of counties)
9.0 M not taking aspirin as recommended
40.1 M with uncontrolled HBP
39.1 M not using statins when indicated
54.1 M combustible tobacco users
70.9 M who are physically inactive
213.1 M missed opportunities
55% of these opportunities are in adults aged 35–64 years
Missed Opportunities to Prevent Cardiovascular Events
+
Wall HK, Ritchey MD, Gillespie C, Omura JD, Jamal A, George MG. Vital Signs: Prevalence of Key
Cardiovascular Disease Risk Factors for Million Hearts 2022 — United States, 2011–2016. MMWR
Morb Mortal Wkly Rep 2018;67:983–991. DOI: http://dx.doi.org/10.15585/mmwr.mm6735a4.
Additional Cause for Concern-Projected U.S. State Level
Prevalence of Adult Obesity / Severe Obesity
• 48.9% obese by
2030
• 24% with severe
obesity
• “given the
difficulty
achieving
meaningful wt
loss, findings
highlight
importance of
prevention”
Ward ZJ, et al. NEJM 2019
Social Determinants of Health:
Zip Code vs. Genetic Code?
• Health varies at a very LOCAL level
• Life expectancy in Atlanta
Status of CV Health Across America
• 2009 BRFSS, > 350K,self report
• 3.3% with ideal CV health (A) ;
– 1.2% Oklahoma
– 6.9% DC
• 9.9% with poor CV health (B: 0-2 metrics)
• Large disparities by age, gender, education, ethnicity
Fang J, et al. J Am Heart Assoc 2012;DOI.1161
(Post-COVID) Future of CVD Prevention
• Past
• Present
• Post-Pandemic Future ?
March 22, 2020 DocMatter Community
• Cases of COVID-19
Worldwide: 372,147
– Deaths 16,310
U.S. 42,161
– Deaths 508
Cases of COVID-19
Worldwide: Approaching 32M
Deaths Approaching 1M
U.S.: Approaching 7M
Deaths > 200K
Johns Hopkins Coronavirus Resource Center,
accessed Sept 23, 2020
Future CVD Prevention ?….Sperling LS. Circulation 2020 On My Mind doi.org/ 10.1161.120.047059
“risk for COVID-related morbidity driven by
interaction of viral illness with unwell
population. Need to invest more than ever in
ESSENTIAL services like CV prevention,
population health initiatives, robust public
health programs…”
Sperling LS. Circulation 2020.
The (Post-COVID) Future of Cardiovascular
Prevention: Unprecedented Times
doi.org/10.1161.120.047059
“cardiovascular and cardiometabolic prevention
must be a high level priority in the post-pandemic
recovery & the era of COVID-19”
“lessons learned during (pandemic) recovery critical
to ensure health of population going forward..”
Dhindsa D, Wong ND, Sperling L Cardiovasc Endo &
Metabol 2020; 9(3): 125-127
“In the midst of difficulty lies
opportunity…”
Albert Einstein
THE FUTURE OF
CARDIOVASCULAR MEDICINE
WILL BE …..
FOCUS ON CV HEALTH
&
PREVENTION
Focus on CV Population Health: The Health/Disease
ContinuumKnapper JT, Quyyumi AA, Mensah GA, Sperling LS. JACC 2015;66:960-7
Normal
Low risk
Normal
High risk
Pre
disease
Early
disease
Late
disease
Health Promotion & Disease Prevention
Contemporary Medicine
H
E
A
L
T
H
D
I
S
E
A
S
E
Social Determinants of Health: Challenges &
InterventionsSchultz WM, Kelli HM, Sandesara P, Quyyumi AA, Mensah GA, Sperling LS. Circulation,
2018.137;2166-2178
•
The Post-COVID Future ?
• Acceleration of New Care Models
– Telehealth / telemedicine
• Decreased use of Ineffective, low-value care
• Volume to value transformation
• Rapid movement to further healthcare integration / consolidation
Need for Comprehensive & Complementary
Prevention Programs(Focus on where we are born, live & work, learn &
play)
• Traditional HC……
• Public / Global Health
• Industry / workplace
• Schools / churches / families/ communities
• Media
• Environmental engineering/architecture
• Government
Success Stories
• Be There San Diego
– Univ. of Best Practices / Right Care Initiative
• Nashville Health
• Kaiser N. California HTN Control
• South Carolina Collaborative
• Minneapolis focus on comprehensive CV risk factors
Fremont A, et al. Health Affairs 2018;37(9):1457-65
Egan BM, et al. J Clin Hypertens 2011;13(8):543-550
PRECISION MEDICINE ?
POPULATION HEALTH ?
Precision Public Health
• Precision Medicine
– Providing right treatment to right patient
at right time
• Precision Public Health
– Providing right intervention to right
population at right time
Khoury MJ, et al. Am J Prev Med 2016;50(3):398-401
Million Hearts® 2022 Aim: Prevent 1 Million Heart Attacks and Strokes in 5 Years
COMMUNITY
Keeping People HealthyOptimizing Care
Priority Populations
Million Hearts® 2022Priorities
Keeping People Healthy
Reduce Sodium Intake
Decrease Tobacco Use
Increase Physical Activity
Optimizing Care
Improve ABCS*
Increase Use of Cardiac Rehab
Engage Patients in
Heart-Healthy Behaviors
Improving Outcomes for Priority Populations
Blacks/African Americans with hypertension
35- to 64-year-olds
People who have had a heart attack or stroke
People with mental and/or substance use disorders
*Aspirin use when appropriate, Blood pressure control, Cholesterol management, Smoking cessation
• Public Health Priorities
– Where CDC & partners can make significant
progress in relatively short time
• Antibiotic Resistance
• HIV Elimination
• Million Hearts
• Opioid Overdose
• Vaccine Preventable Disease
• Viral Hepatitis
The Future? J. Auerbach. J Public Health Manag Pract 2016;22(3): 215-18
•
• Identify vectors / complex causes
• Identify barriers / roadblocks / factors that
propagate
• Goals:
– Control
– Elimination
– Eradication
Approach to Cardiovascular &
Cardiometabolic Epidemics / Pandemics ?
(Post- COVID) Future of CVD
Prevention: At A Crossroads?
• COVID impacts CV system, CV care, and outcomes
• CV Health & Prevention remain a priority in the midst of pandemic
• Future- greater need for integration of healthcare and public health at level of community
The Future ??
“It’s tough to make predictions, especially about the future”
Yogi Berra
“It is not in the stars to hold our destiny but in ourselves.”
William Shakespeare
thanks